{"id":"https://openalex.org/W2017544610","doi":"https://doi.org/10.1186/1477-7525-6-100","title":"Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey","display_name":"Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey","publication_year":2008,"publication_date":"2008-11-14","ids":{"openalex":"https://openalex.org/W2017544610","doi":"https://doi.org/10.1186/1477-7525-6-100","mag":"2017544610","pmid":"https://pubmed.ncbi.nlm.nih.gov/19014588","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2596785"},"language":"en","primary_location":{"id":"doi:10.1186/1477-7525-6-100","doi":"https://doi.org/10.1186/1477-7525-6-100","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1477-7525-6-100","pdf_url":"https://hqlo.biomedcentral.com/counter/pdf/10.1186/1477-7525-6-100","source":{"id":"https://openalex.org/S77368557","display_name":"Health and Quality of Life Outcomes","issn_l":"1477-7525","issn":["1477-7525"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health and Quality of Life Outcomes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://hqlo.biomedcentral.com/counter/pdf/10.1186/1477-7525-6-100","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076243239","display_name":"Olympia C. Hadjimichael","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olympia Hadjimichael","raw_affiliation_strings":["Health Economics and Outcomes Research, Teva Neuroscience, Inc,, Kansas City, MO 64131, USA. ohadjimichael@gmail.com","Department of Neurology, Yale University School of Medicine, New Haven, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, Teva Neuroscience, Inc,, Kansas City, MO 64131, USA. ohadjimichael@gmail.com","institution_ids":[]},{"raw_affiliation_string":"Department of Neurology, Yale University School of Medicine, New Haven, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046218660","display_name":"Timothy L. Vollmer","orcid":"https://orcid.org/0000-0002-1539-9830","observed_orcids":["https://orcid.org/0000-0002-1539-9830"]},"institutions":[{"id":"https://openalex.org/I1324766304","display_name":"Barrow Neurological Institute","ror":"https://ror.org/01fwrsq33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324766304","https://openalex.org/I1325481341","https://openalex.org/I2802827176"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Vollmer","raw_affiliation_strings":["Barrow Neurological Institute, CMSC/NARCOMS Project, Phoenix, AZ, 85013, USA","Barrow Neurological Institute, CMSC/NARCOMS Project, Phoenix, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrow Neurological Institute, CMSC/NARCOMS Project, Phoenix, AZ, 85013, USA","institution_ids":["https://openalex.org/I1324766304"]},{"raw_affiliation_string":"Barrow Neurological Institute, CMSC/NARCOMS Project, Phoenix, USA","institution_ids":["https://openalex.org/I1324766304"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113477994","display_name":"MerriKay A. Oleen-Burkey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"MerriKay Oleen-Burkey","raw_affiliation_strings":["Health Economics and Outcomes Research, Teva Neuroscience, Inc., Kansas City, MO, 64131, USA","Health Economics and Outcomes Research, Teva Neuroscience, Inc., Kansas City, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, Teva Neuroscience, Inc., Kansas City, MO, 64131, USA","institution_ids":[]},{"raw_affiliation_string":"Health Economics and Outcomes Research, Teva Neuroscience, Inc., Kansas City, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113477994"],"corresponding_institution_ids":[],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":8.0266,"has_fulltext":true,"cited_by_count":255,"citation_normalized_percentile":{"value":0.9800109,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"6","issue":"1","first_page":"100","last_page":"100"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11282","display_name":"Fibromyalgia and Chronic Fatigue Syndrome Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.9819999933242798},{"id":"https://openalex.org/keywords/fatigue-severity-scale","display_name":"Fatigue Severity Scale","score":0.8080000281333923},{"id":"https://openalex.org/keywords/modified-fatigue-impact-scale","display_name":"Modified Fatigue Impact Scale","score":0.9990000128746033},{"id":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis","display_name":"primary progressive multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/disability-severity","display_name":"disability severity","score":0.4580000042915344},{"id":"https://openalex.org/keywords/patient-determined-disease-steps","display_name":"Patient-Determined Disease Steps","score":0.8579999804496765},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.8140000104904175},{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":1.0},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7730467319488525},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.659082293510437},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6137688755989075},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.516846239566803},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4876317083835602},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3242897391319275},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2082485556602478},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D009128","descriptor_name":"Muscle Spasticity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009656","descriptor_name":"North America","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011594","descriptor_name":"Psychometrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018434","descriptor_name":"Sickness Impact Profile","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/1477-7525-6-100","doi":"https://doi.org/10.1186/1477-7525-6-100","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1477-7525-6-100","pdf_url":"https://hqlo.biomedcentral.com/counter/pdf/10.1186/1477-7525-6-100","source":{"id":"https://openalex.org/S77368557","display_name":"Health and Quality of Life Outcomes","issn_l":"1477-7525","issn":["1477-7525"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health and Quality of Life Outcomes","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2596785","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2596785","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Qual Life Outcomes","raw_type":"Text"},{"id":"pmid:19014588","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19014588","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health and quality of life outcomes","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f595a2d1bba3497faf7f9c361a9ce28d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f595a2d1bba3497faf7f9c361a9ce28d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health and Quality of Life Outcomes, Vol 6, Iss 1, p 100 (2008)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1477-7525-6-100","doi":"https://doi.org/10.1186/1477-7525-6-100","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1477-7525-6-100","pdf_url":"https://hqlo.biomedcentral.com/counter/pdf/10.1186/1477-7525-6-100","source":{"id":"https://openalex.org/S77368557","display_name":"Health and Quality of Life Outcomes","issn_l":"1477-7525","issn":["1477-7525"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health and Quality of Life Outcomes","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017544610.pdf","grobid_xml":"https://content.openalex.org/works/W2017544610.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W24020054","https://openalex.org/W42114613","https://openalex.org/W155259919","https://openalex.org/W1735043105","https://openalex.org/W1976470160","https://openalex.org/W1976470756","https://openalex.org/W1983334940","https://openalex.org/W1996308597","https://openalex.org/W1996607415","https://openalex.org/W2003189347","https://openalex.org/W2003376998","https://openalex.org/W2003921589","https://openalex.org/W2012094802","https://openalex.org/W2016566026","https://openalex.org/W2019441593","https://openalex.org/W2019994407","https://openalex.org/W2024996364","https://openalex.org/W2027661319","https://openalex.org/W2030843522","https://openalex.org/W2036805773","https://openalex.org/W2038316210","https://openalex.org/W2040877423","https://openalex.org/W2043241239","https://openalex.org/W2066124230","https://openalex.org/W2070378374","https://openalex.org/W2073646922","https://openalex.org/W2075701207","https://openalex.org/W2076989760","https://openalex.org/W2080623630","https://openalex.org/W2084110857","https://openalex.org/W2086826898","https://openalex.org/W2093905014","https://openalex.org/W2094812481","https://openalex.org/W2108230902","https://openalex.org/W2109158135","https://openalex.org/W2111468824","https://openalex.org/W2112165124","https://openalex.org/W2114242035","https://openalex.org/W2120265437","https://openalex.org/W2127671643","https://openalex.org/W2131697440","https://openalex.org/W2134337525","https://openalex.org/W2151475520","https://openalex.org/W2153084624","https://openalex.org/W2170689912","https://openalex.org/W2176880214","https://openalex.org/W2396665015","https://openalex.org/W2398974789","https://openalex.org/W2399506214","https://openalex.org/W4236379077","https://openalex.org/W4256474774","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2937440369","https://openalex.org/W4282048209","https://openalex.org/W4389460345","https://openalex.org/W2120265437","https://openalex.org/W4210466376","https://openalex.org/W4408557494","https://openalex.org/W7140247657","https://openalex.org/W2469917263","https://openalex.org/W4389375959","https://openalex.org/W2947358173"],"abstract_inverted_index":{"BACKGROUND:":[0],"Fatigue":[1,123,130],"is":[2],"a":[3,13,344],"common":[4],"disabling":[5],"symptom":[6],"of":[7,19,53,65,74,139,205,215,224,242,250,266,285,317],"multiple":[8],"sclerosis":[9],"(MS)":[10],"and":[11,63,67,100,103,107,127,134,146,235,340],"has":[12],"significantly":[14],"negative":[15],"impact":[16,64,265,335],"on":[17,31,60,336],"quality":[18],"life.":[20],"Persons":[21],"with":[22,70,196,233,289,338],"MS":[23,75,231,326,339],"enrolled":[24],"in":[25,88,162,229,261,277,287],"the":[26,61,84,111,122,128,137,176,187,197,200,247,251,262,278,318],"North":[27],"American":[28],"Research":[29],"Committee":[30],"Multiple":[32],"Sclerosis":[33],"(NARCOMS)":[34],"Patient":[35],"Registry":[36,89,150],"are":[37],"invited":[38],"to":[39,46,58,83,155,298,307],"complete":[40],"follow-up":[41],"surveys":[42,55,91],"every":[43],"six":[44,280],"months":[45,281],"update":[47,90,151],"their":[48,334],"original":[49],"registration":[50],"information.":[51],"One":[52],"these":[54],"was":[56,153,170,189,210,227,244,313],"designed":[57],"focus":[59],"severity":[62,203,263],"fatigue,":[66,143],"its":[68],"association":[69],"other":[71],"clinical":[72],"parameters":[73],"such":[76,92],"as":[77,93,194],"physical":[78],"disability.":[79],"METHODS:":[80],"In":[81],"addition":[82],"usual":[85],"data":[86],"collected":[87],"demographic":[94],"characteristics,":[95],"MS-related":[96],"medical":[97],"history,":[98],"disability":[99,248],"handicap,":[101],"immunomodulatory":[102,269],"symptomatic":[104,140],"therapies":[105],"taken,":[106],"healthcare":[108],"services":[109],"used,":[110],"survey":[112,152,188,320],"for":[113,142,172,186,311,343],"this":[114],"study":[115],"included":[116],"two":[117],"validated":[118],"self-report":[119],"fatigue":[120,193,226,243,267,288,291,312,329],"scales,":[121],"Severity":[124],"Scale":[125,132],"(FSS)":[126],"Modified":[129],"Impact":[131],"(MFIS)":[133],"questions":[135],"about":[136,333],"use":[138],"management":[141],"both":[144],"pharmacologic":[145],"non-pharmacologic":[147],"treatments.":[148],"This":[149],"mailed":[154],"all":[156],"NARCOMS":[157],"registrants":[158],"(n":[159,218],"=":[160,208,219],"18,595)":[161],"November":[163],"2002.":[164],"Information":[165],"provided":[166],"by":[167,175,212,268,315],"registry":[168],"participants":[169],"approved":[171],"research":[173],"purposes":[174],"Yale":[177],"University":[178],"Institutional":[179],"Review":[180],"Board.":[181],"RESULTS:":[182],"The":[183],"response":[184],"rate":[185],"49.5%":[190],"(9205/18,595).":[191],"Severe":[192],"measured":[195],"FSS":[198],"using":[199],"developer's":[201],"recommended":[202],"cutpoint":[204],">":[206],"or":[207,264],"36":[209],"reported":[211,282,293],"6691":[213],"(74%)":[214],"evaluable":[216],"respondents":[217,272,321],"9077).":[220],"A":[221,239],"higher":[222],"prevalence":[223],"severe":[225],"observed":[228,245],"relapsing-worsening":[230],"compared":[232],"relapsing-stable":[234],"primary":[236],"progressive":[237],"MS.":[238],"distinct":[240],"pattern":[241],"across":[246],"levels":[249,292],"Patient-Determined":[252],"Disease":[253],"Steps":[254],"(PDDS).":[255],"Although":[256],"there":[257],"were":[258],"no":[259],"differences":[260],"agents":[270],"(IMA),":[271],"who":[273],"recalled":[274],"therapy":[275,310],"changes":[276],"prior":[279],"different":[283],"patterns":[284],"change":[286],"lower":[290],"after":[294,302],"changing":[295,303],"from":[296,304],"interferon-beta":[297],"glatiramer":[299,305],"acetate":[300,306],"than":[301],"interferon-beta.":[308],"Concomitant":[309],"used":[314],"47.2%":[316],"5799":[319],"receiving":[322],"IMA.":[323],"CONCLUSION:":[324],"Characterizing":[325],"symptoms":[327],"like":[328],"can":[330],"increase":[331],"awareness":[332],"persons":[337],"suggest":[341],"recommendations":[342],"care":[345],"plan.":[346]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":17},{"year":2021,"cited_by_count":23},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}